(1 - 30 von 40
)
::: Star Campus :::
archive.thedailystar.net
Best-Templates : The Best Place For Web Templates - Provides free web-templates, web designing guides, software guides, free web-based e-mail and more GET...
NZZ: Just married | NZZ
— Stefanie Pfaffen und Dragan Grabulovski Stefanie Pfaffen, 30, und Dragan Grabulovski, 33, haben am 21. Mai in der Kollegiumskirche in ... › just_married-ld
Covagen enters into a strategic research collaboration and license...
www.informazione.it
Dragan Grabulovski, Ph.D., chief scientific officer of Covagen, added: "This agreement underlines the value of our FynomAb platform as a ...
Gewinner des Venture-Wettbewerbs stehen fest | Netzwoche
www.netzwoche.ch
Die ETH Zürich, EPF Lausanne, McKinsey, Knecht und KTI haben die diesjährigen Gewinner des Venture-Start-up-Wettbew
Berlin Cures verstärkt Business Advisory Board mit der Ernennung...
www.ots.at
Berlin Cures verstärkt Business Advisory Board mit der Ernennung von Ulf Berg, Ph.D. und Dragan Grabulovski, Ph.D. Zug, Schweiz (ots/PRNewswire)-Der Arzneimittelentwickler Berlin Cures gab heute die Gründung eines Geschäftsbeirates (Business Advisory Board (BAB)) und die Ernennung der ersten beiden Mitglieder, Dr. Ulf Berg und Dr. Dragan Grabulovski, bekannt.
Berlin Cures strengthens Business Advisory Board …
www.finanznachrichten.de
Internationally Renowned Industry Veterans Provide Strategic Developmental Experience for the Company's Transition to a Global Commercial Entity ZUG, Switzerland, June 27, PRNewswire/
Covagen und Mitsubishi Tanabe kooperieren bei der Entwicklung ...
www.med-kolleg.de
Dr. Dragan Grabulovski, CSO von Covagen, ergänzt: ?Diese Vereinbarung unterstreicht den Wert unserer FynomAb-Plattform als Quelle innovativer bispezifischer Biologika mit hervorragenden biophysikalischen ...
Berlin Cures verstärkt Business Advisory Board mit …
www.wallstreet-online.de
International renommierte Branchen-Veteranen bringen strategische Entwicklungserfahrung mit, um das Unternehmen in eine weltweit operierende, gewinnorientierte Organisation zu verwandeln ZUG ...
Covagen und Mitsubishi Tanabe kooperieren bei der Entwicklung...
www.ots.at
Das Schweizer Biotechnologieunternehmen Covagen hat nach eigenen Angaben eine strategische Forschungskooperations- und Lizenzvereinbarung mit dem...
Janssen Affiliate Cilag GmbH International Acquires Covagen AG
www.finanznachrichten.de
- Clinical Candidate COVA 322 and FynomAb® Technology Platform Further Strengthen Immunology Portfolio and Capabilities ZUG, Switzerland, Aug. 25,
Araris Biotech AG kicks-off with CHF2.5m seed financing - European...
european-biotechnology.com
Zurich-based ADC maker Araris Biotech AG announced the closing of an oversubscribed seed financing round of CHF2.5m with Redalpine, Schroder Adveq and VI...
Berlin Cures strengthens Business Advisory Board with the...
www.finanzen.at
· Ulf Berg and Dr. Dragan Grabulovski. The BAB's role will be to provide ongoing counsel, along with strategic guidance in business development ...
Araris Biotech AG closes seed financing round of CHF 2.5 millionwww.psi.ch › PSI Home › Industrie
www.psi.ch
The funding will allow Araris to progress quickly towards generating key proof of principle data”, says Dragan Grabulovski, co-founder and chairman of the ...
Araris Biotech AG closes seed financing round of CHF 2.5m
www.vipartners.ch
Dragan Grabulovski, co-founder and chairman of the board, added: “Obtaining a seed financing from VCs just six months after incorporation of Araris validates ... › news
Covagen to collaborate with Mitsubishi for research
biospectrumasia.com
Dr Dragan Grabulovski, chief scientific officer of Covagen, added: "This agreement underlines the value of our FynomAb platform as a source of innovative bispecific biologics with excellent biophysical properties and positions our company as a highly attractive partner for the development of next ...
Communiqué de presse - Novartis
cws.huginonline.com
Francis Waldvogel, Chairman des Novartis Venture Fund; und Dragan Grabulovski, Chief Science Officer von Covagen. Über Novartis
Close Biotechgate Biotechgate | | Twitter LinkedIn Google+ ...
www.cypriotbiotech.com
Dragan Grabulovski, Ph.D., chief scientific officer of Covagen, added, "The expansion to a second bispecific FynomAb program is the result of the successful discovery and early preclinical development of the FynomAb from the original collaboration. This FynomAb was generated less than one year after ...
Araris Biotech bekommt 2,5 Millionen Franken - punkt4
punkt4.info
... von Araris bestätigt das Interesse an unserer neuartigen Linker-ADC-Technologie“, wird Dragan Grabulovski, Araris-Mitbegründer und CEO, zitiert. › social-news › news › araris-biotec...
Araris obtains CHF 2.5 million funding | Industry
www.psi.ch
— ... to progress quickly towards generating key proof of principle data”, says Dragan Grabulovski, co-founder and chairman of the board. › ... › Industry
Covagen与Roche扩大Fynomers平台药物研发的合作协议_公司动态_行业动态_
www.labbase.net
Dr. Dragan Grabulovski, CSO and co-founder of Covagen added: "Roche is one of the leading science-based healthcare companies in the field ...
ETH Zurich spin-out Covagen seals protein engineering deal with Roche...
sciencebusiness.net
CollaborationETH Zurich spin-out Covagen has announced an agreement with … giant Roche, under which Covagen will use its protein engineering...
Araris Biotech Completes CHF Million Seed Financing Roundwww.globenewswire.com › › Araris-Bio...
www.globenewswire.com
· Dragan Grabulovski, Ph.D. co-founder and founding chairman of Araris added, “The quality of the investors reflects the quality of the ...
News - Microcaps
www.microcaps.ch
Dragan Grabulovski and Ronald Kogens have been elected to the Board of Directors of Microcaps, bringing extensive expertise in business development, ... › news
May Member News & Networking | ASCO Connection
connection.asco.org
The LUNGevity Foundation announced that Julie Brahmer, MD, Associate Professor of Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,...
Getting fired up over FynomAbs | Drug Discovery Newswww.drugdiscoverynews.com › getting-fired-up-ov...
www.drugdiscoverynews.com
· Dragan Grabulovski,” explains Papatheodorou. “Our uniqueness is that we can fuse Fynomers to all possible ends of the antibody and as such ...
Araris Biotech bekommt 2,5 Millionen Franken | Greater Zurich
www.greaterzuricharea.com
— ... bestätigt das Interesse an unserer neuartigen Linker-ADC-Technologie“, wird Dragan Grabulovski, Araris-Mitbegründer und CEO, zitiert. › news › araris-biote...
Covagen and Roche extend collaboration on the use of ...
pipelinereview.com
— Dragan Grabulovski, CSO and co-founder of Covagen added: "Roche is one of the leading science-based healthcare companies in the field of ... › Covag...
Roche and Covagen collaborate - PMLiVE
www.pmlive.com
Roche has entered into a collaboration agreement with Covagen, a Swiss biotechnology company
Neuzugänge bei Startup-Supportern und -Investoren
www.startupticker.ch
— Der Zürcher Venture Capital Fonds Pureos Bioventures gibt die Ernennung neuer Venture Partner bekannt. Dragan Grabulovski, Ian Metcalfe und ... › news › neuzugaenge-bei-...
sortiert nach Relevanz / Datum